Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study

AIM: To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib for hepatocellular carcinoma (HCC). METHODS: Fourteen advanced HCC patients who received sorafenib 400/800 mg/d for at lea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shiozawa, Kazue, Watanabe, Manabu, Kikuchi, Yoshinori, Kudo, Takahide, Maruyama, Kenichi, Sumino, Yasukiyo
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Co., Limited 2012
Matèries:
Brief Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3484345/
https://ncbi.nlm.nih.gov/pubmed/23155317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i40.5753
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars